Specialty
Category Archives: Cancer and neoplasms
The newly published report by IMARC Group, titled ”Adrenal Cortex Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the adrenal cortex neoplasms market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the […]
LeukoStrat CDx FLT3 Mutation Assay Is Approved to Help Identify Patients With AML Who Are Eligible for Quizartinib The FDA has approved the LeukoStrat CDx FLT3 Mutation Assay to help identify patients who are eligible to receive treatment with quizartinib (Vanflyta). Quizartinib was recently approved for patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML).1 That assay is a […]
Julie Huynh-Lu, PA-C Oncology nurses must know what to look for — and what questions to ask — when treating patients with myeloproliferative neoplasms (MPNs), as side effects and other patient characteristics can play a role in determining the best treatment regimen, according to Julie Huynh-Lu, PA-C, a physician assistant from The University of Texas […]
Cancer and neoplasms
Liver Cancer Market is Expected to Showcase a Significant Growth During the Forecast Period (2023-2032), Predicts DelveInsight | Key Companies – Surface Oncology, MiNA Therapeutics, Ocuphire Pharma, Medivir, Celldex Therapeutics, Eli Lilly, Genetech, GlaxoSmithKline, Bristol-Myers Squibb |
The newly published report by IMARC Group, titled ”Skin Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the skin neoplasms market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, […]